| The Effect of an RBAC Supplement (BRM4) on NAFLD (NCT02568787) | University of Miami | 2016-05-01 |
| Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects (NCT02681055) | MediciNova | 2016-03-01 |
| Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease (NCT02947568) | University of Pecs | 2016-03-01 |
| Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes (NCT02686476) | Medanta, The Medicity, India | 2016-03-01 |
| SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis (NCT02696941) | University of Oxford | 2016-02-01 |
| Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease (NCT05560997) | Yan Bi | 2016-01-05 |
| Efficacy of Phosphatidylcholine in NAFLD (NCT04411862) | Nehal Abou Seada | 2016-01-02 |
| Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver Disease (NCT02950610) | University of Edinburgh | 2016-01-01 |
| Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection) (NCT02663388) | University of Lorraine | 2016-01-01 |
| Prebiotics in Patients With Non-alcoholic Liver Disease (NCT02642172) | Kaplan Medical Center | 2016-01-01 |
| Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes (NCT02637973) | The Deutsche Diabetes Forschungsgesellschaft e.V. | 2015-12-01 |
| Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment (NCT01987310) | Sheba Medical Center | 2015-12-01 |
| Vitamin D in Fatty Liver Disease (NCT04038853) | University Hospital Rijeka | 2015-12-01 |
| SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD (NCT02649465) | Kanazawa University | 2015-11-11 |
| Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease (NCT02779946) | University of Leipzig | 2015-10-01 |
| The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/Steatohepatitis (NCT02528305) | University of Bath | 2015-10-01 |
| Quantifying Steatosis in Liver Transplant Donors (NCT02579408) | The University of Hong Kong | 2015-10-01 |
| Serine Supplementation for Obese Subjects With Fatty Liver Disease (NCT02599038) | Hanns-Ulrich Marschall | 2015-10-01 |
| Effect of Probiotic and Smectite Gel on NAFLD (NCT03614039) | Nazarii Kobyliak | 2015-09-15 |
| Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress (NCT02650830) | Yonsei University | 2015-09-12 |
| Hepatic Inflammation and Physical Performance in Patients With NASH (NCT02526732) | Priv.-Doz. Dr. J. Schattenberg | 2015-09-01 |
| The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults (NCT03142867) | The Geneva Foundation | 2015-08-25 |
| Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) (NCT02369536) | Neuromed IRCCS | 2015-08-18 |
| Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver Disease (NCT03791203) | Universiti Sains Malaysia | 2015-08-01 |
| The Effects of Type of Exercise in Non-alcoholic Fatty Liver Disease (NCT02679417) | Mahidol University | 2015-08-01 |
| Low Calorie Diet and Diabetes (NCT02498990) | Karolinska University Hospital | 2015-08-01 |
| ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD (NCT02330549) | Tobira Therapeutics, Inc. | 2015-07-17 |
| Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth (NCT02461212) | Emory University | 2015-07-01 |
| Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients (NCT03128918) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2015-07-01 |
| Fatty Liver Disease Collaborative Research in China (NCT02391168) | Fatty Liver and Alcoholic Liver Disease Study Group, China | 2015-07-01 |
| Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors (NCT02716870) | University of Toronto | 2015-06-01 |
| Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients (NCT03250572) | Ain Shams University | 2015-06-01 |
| Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease (NCT02488941) | University of Aarhus | 2015-06-01 |
| Protein-rich Diet and NAFLD in Bariatric Surgery (NCT02400099) | Catholic University of the Sacred Heart | 2015-06-01 |
| Fructose and Liver Diseases in Youth: Help Them FLY (NCT05528471) | University of Alberta | 2015-04-30 |
| Short Term Intermittent Fasting and Insulin Resistance (NCT02420054) | University of Copenhagen | 2015-04-01 |
| Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes (NCT02303730) | Fudan University | 2015-03-01 |
| Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH (NCT02390232) | University Hospital, Toulouse | 2015-02-01 |
| Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study (NCT02366052) | Johannes Gutenberg University Mainz | 2015-02-01 |
| Probiotics in the Treatment of NAFLD (NCT02764047) | Federal University of Health Science of Porto Alegre | 2015-01-01 |
| Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia (NCT02337660) | University Hospital, Gentofte, Copenhagen | 2015-01-01 |
| Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease (NCT02303314) | Shiraz University of Medical Sciences | 2014-11-01 |
| A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD (NCT02285205) | Yonsei University | 2014-11-01 |
| Effect of Exercise on Hepatic Fat in Overweight Children (NCT02258126) | University of the Basque Country (UPV/EHU) | 2014-11-01 |
| Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects (NCT02242149) | Universidade Federal do Rio de Janeiro | 2014-10-14 |
| Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression (NCT02267148) | UNC Nutrition Research Institute | 2014-10-01 |
| "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population (NCT02248311) | Hospital Universitari Vall d'Hebron Research Institute | 2014-09-01 |
| Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects (NCT02147925) | Sun Yat-sen University | 2014-08-01 |
| Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease (NCT02860884) | Rennes University Hospital | 2014-08-01 |
| The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease (NCT02178839) | Urmia University of Medical Sciences | 2014-07-01 |
| The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease (NCT02134522) | Yale University | 2014-06-01 |
| Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk (NCT02702479) | University of Toronto | 2014-06-01 |
| Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLD (NCT02124577) | University of California, San Diego | 2014-05-01 |
| Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease (NCT02132780) | Virginia Commonwealth University | 2014-05-01 |
| Antidiabetic Effects on Intrahepatic Fat (NCT03068065) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2014-05-01 |
| Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C Virus (NCT03276039) | Ain Shams University | 2014-04-15 |
| Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents (NCT02116192) | University of Wisconsin, Madison | 2014-04-01 |
| Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD (NCT02285218) | Yonsei University | 2014-04-01 |
| Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT03281083) | Duke-NUS Graduate Medical School | 2014-03-28 |
| A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases (NCT02077374) | Conatus Pharmaceuticals Inc. | 2014-03-01 |
| Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients (NCT01975935) | University of Michigan | 2014-01-01 |
| The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver (NCT01956825) | Meir Medical Center | 2014-01-01 |
| Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference. (NCT01985009) | Echosens | 2014-01-01 |
| Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease (NCT01963845) | University of California, San Diego | 2014-01-01 |
| Urinary Metabonomics of Two Major Patterns of NAFLD (NCT02077283) | ShuGuang Hospital | 2014-01-01 |
| Investigation of Synbiotic Treatment in NAFLD (NCT01680640) | University Hospital Southampton NHS Foundation Trust | 2013-12-01 |
| Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients (NCT02491905) | Huons Co., Ltd. | 2013-11-01 |
| Fatty Liver Patient Registry (NCT02298439) | University Health Network, Toronto | 2013-10-01 |
| Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients (NCT01999101) | Phenex Pharmaceuticals AG | 2013-10-01 |
| The Influence of Autophagy on Fatty Liver (NCT01988441) | Far Eastern Memorial Hospital | 2013-09-01 |
| Amlexanox for Type 2 Diabetes and Obesity (NCT01842282) | University of Michigan | 2013-07-19 |
| NAFLD in Adolescents and Young Adults With PCOS (NCT02506946) | Columbia University | 2013-07-01 |
| Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery (NCT01856465) | Johane Allard | 2013-06-01 |
| Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD (NCT02075164) | Prof. Michael Trauner, MD | 2013-05-01 |
| Genetic Studies of Non-Alcoholic Fatty Liver Disease (NCT01629095) | National Human Genome Research Institute (NHGRI) | 2013-04-23 |
| Effect of Ginger Supplement on Non-alcoholic Fatty Liver (NCT02535195) | Dr Azita Hekmatdoost | 2013-03-01 |
| Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver (NCT02682173) | University Hospital, Basel, Switzerland | 2013-03-01 |
| Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study (NCT01285362) | Columbia University | 2013-03-01 |
| Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group (NCT01754714) | Abbott | 2012-12-01 |
| An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis (NCT02174367) | King's College London | 2012-11-01 |
| Effect of Phytosterols on Nonalcoholic Fatty Liver Disease (NCT01875978) | China Medical University Hospital | 2012-10-01 |
| Effect on Liver Histology of Vitamin D in Patients With Non-alcoholic Steatohepatitis (NCT01623024) | University of Palermo | 2012-09-01 |
| Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease (NCT01680003) | Nova Laboratories Sdn Bhd | 2012-09-01 |
| Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease (NCT01712711) | Tehran University of Medical Sciences | 2012-09-01 |
| Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD) (NCT02038387) | University of Roma La Sapienza | 2012-07-01 |
| Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease (NCT01874249) | Fundación Clínica Médica Sur | 2012-07-01 |
| The Effect of Protein-enriched Diet on Body Composition and Appetite (NCT01634048) | Imperial College London | 2012-07-01 |
| Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy (NCT02644239) | University of Sao Paulo | 2012-06-01 |
| The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver Disease (NCT01619215) | King Saud University | 2012-06-01 |
| Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT02006498) | University of Malaya | 2012-06-01 |
| Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease (NCT01759628) | Tehran University of Medical Sciences | 2012-04-01 |
| Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis (NCT01654549) | Tehran University of Medical Sciences | 2012-04-01 |
| Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) (NCT01083992) | Ziv Hospital | 2012-04-01 |
| Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease (NCT01556113) | Yale University | 2012-03-01 |
| Histological Improvement of NASH With Prebiotic (NCT03184376) | University of Calgary | 2012-02-28 |
| Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study. (NCT01696487) | Medical University of Vienna | 2012-02-01 |
| Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD) (NCT01511523) | Biovil Research Group, LLC | 2012-01-01 |
| Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation (NCT01579162) | HepQuant, LLC | 2012-01-01 |
| Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD) (NCT01472120) | Gulhane School of Medicine | 2011-12-01 |
| Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes (NCT01492283) | University Hospital, Gentofte, Copenhagen | 2011-12-01 |